Daniel Auclair, President of Hematocure and Senior Vice President of Business Development at Predicta Biosciences, shared on X:
“The issue of ultra high-risk myeloma and how to assess it was a big topic at the Myeloma Society
Genomics Meeting in Poland last month and I expect we will hear more at IMS26 in a few weeks. Looking forward to seeing you in Glasgow.
This is why many of us like so much Whole Genome Sequencing (WGS) which solves all these issues as elegantly presented by Garces and Maura recently.”
Title: Time to say adieu to FISH in myeloma diagnostics
Time to say adieu to FISH in myeloma diagnostics
Authors: Juan-Jose Garces, Francesco Maura
You can also read: Myeloma Paper of the Day, August 23th, Suggested by Robert Orlowski
